BOSTON SCIENTIFIC CORPORATION Increase (Decrease) in Other Operating Liabilities
BOSTON SCIENTIFIC CORPORATION (BSX) reported Increase (Decrease) in Other Operating Liabilities of $153.00 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2021-08-06
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for the quarter ending 2021-06-30 was $137.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for the quarter ending 2021-03-31 was $16.00M, a 61.90% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for the quarter ending 2020-06-30 was -$223.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for the quarter ending 2020-03-31 was $42.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for fiscal 2020 was -$116.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for fiscal 2019 was -$18.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for fiscal 2018 was -$1.16B.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating liabilities for fiscal 2010 was -$404.00M, a 245.32% decline from fiscal 2009.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|
| 2021-06-30 | $137.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $153.00M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $16.00M 10-Q · filed 2021-05-06 | ||
| 2020-12-31 | -$116.00M 10-K · filed 2021-02-23 | ||
| 2020-06-30 | -$223.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$181.00M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $42.00M 10-Q · filed 2021-05-06 | ||
| 2019-12-31 | -$18.00M 10-K · filed 2021-02-23 | ||
| 2018-12-31 | -$1.16B 10-K · filed 2021-02-23 | ||
| 2010-12-31 | -$404.00M 10-K · filed 2011-02-17 | ||
| 2009-12-31 | $278.00M 10-K · filed 2011-02-17 | ||
| 2008-12-31 | -$416.00M 10-K · filed 2011-02-17 | ||
| 2007-12-31 | $125.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |